Permeation of vanadium(III, IV, V)-dipicolinate complexes across MDCK cell monolayer and comparison with Caco-2 cells

Chinese Science Bulletin

Volumn 50, Issue 17, 2005, Pages 1854-1859

  Zhang, Yue ^a   Yang, Xiaoda ^a   Wang, Kui ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Caco 2; Diabetes; Intestinal absorption; MDCK; Vanadium complex

Indexed keywords

ANIMALIA;

EID: 33749835663     PISSN: 10016538     EISSN: 18619541     Source Type: Journal    
DOI: 10.1360/982005-102     Document Type: Article

References (23)

1. Shechter, Y., Shisheva, A., Vanadium salts and the future treatment of diabetes, Endeavour, 1993, 17(1): 27-31.
2. Shechter, Y., Karlish, S. J., Insulin-like stimulation of glucose oxidation in rat adipocytes by vanadyl(IV) ions, Nature, 1980, 284(5756): 556-558.
3. Posner, B. I., Faure, R., Burgess, J. W. et al., Peroxovanadium compounds: A new class of potent phosphotyrosine phosphate inhibitors which are insulin mimetics, J. Biol. Chem., 1994, 269(6): 4596-4604.
4. Fantus, I. G., Tsiani, E., Multifunctional actions of vanadium compounds on insulin signaling pathways: evidence for preferential enhancement of metablic versus mitogenic effects, Mol. Cell Biochem., 1998, 182(1-2): 109-119.
5. Thompson, K. H., McNeill, J. H., Orvig, C., Vanadium compounds as insulin mimics, Chem. Rev., 1999, 99(9): 2561-2572.
6. Yuen, V. G., Orvig, C., McNeill, J., Glucose-lowering effects of a new organic vanadiumcomplex: bis(maltolato)oxovanadium(IV), Can. J. Physiol. Pharmacol., 1995, 73(1): 55-64.
7. McNeill, J. H., Yuen, V. G., Hoveyda, H. R. et al., Bis(maltolato) oxovanadium(IV) is a potent insulin mimic, J. Med. Chem., 1992, 35: 1489-1491.
8. Crans, D. C., Chemistry and insulin-like properties of vanadium(IV) and vanadium(V) compounds, J. Inorg. Biochem., 2000, 80: 123-131.
9. Reul, A. B., Amin, S. S., Buchet, J. P. et al., Effects of vanadium complexes with organic ligands on glucose metabolism: a comparison study in diabetic rats, Br. J. Pharmacol., 1999, 126: 467-477.
10. Thompson, K., Yuen, V. G., McNeill, J. H. et al., Chemical and Pharmacological Studies of a New Class of Antidiabetic Vanadium Complexes in Vanadium Compounds, Cary NC: Oxford University Press, 2001, 329-352.
11. Nadai, M., Watanabe, H., Fujiwara, C. et al., Mechanism on insulin-like action of vanadyl sulfate: studies on interaction between rat adipocytes and vanadium compounds, Biol. Pharm. Bull., 1995, 18: 719-725.
12. Li, J., Elberg, G., Crans, D. C. et al., Evidence for the distinct vanadyl(+4) dependent activating system for manifesting insulin-like effects, Biochem., 1996, 35: 8314-8318.
13. Sakurai, H., Fujii, K., Watanabe, H. et al., Orally active and long-term action insulin-mimetic vanadylcomplex: bis(picolinato) oxovanadium(IV), Biochem. Biophys. Res. Commun., 1995, 214: 1095-1101.
14. Artursson, P., Borchardt, R. T., Intestinal drug absorption and metabolism in cell cultures: Caco-2 and beyond, Pharm. Res., 1997, 14: 1655-1658.
15. Cho, M. J., Thompson, D. P., Cramer, C. T. et al., The Madin Darby canine kidney (MDCK) epithelial cell monolayer as a model cellular transport barrier, Pharm. Res., 1989, 6: 71-77.
16. Markowska, M., Oberle, R., Juzwin, S. et al., Optimizing Caco-2 cell monolayers to increase thoughtput in drug intestinal absorption analysis, J. Pharmacol. Toxicol. Method, 2001, 46(1): 51-55.
17. Li, J., Albert, P., Screening for human ADME/Tox drug properties in drug discovery, Drug Discov. Today, 2001, 6(7): 357-366.
18. Yang, X. G., Yuan, L., Wang, K. et al., Comparison of intestinal absorption of two insulin-mimic vanadyl complexes using Caco-2 monolayers as model system, Chinese Science Bulletin, 2002, 47: 1550-1555.
19. Annette, B., Sibylle, H., Kayoshi, S. et al., Cell cultures as tools in biopharmacy, Pharm. Sci., 2000, 2: 551-560.
20. Mitchell, E., Lisbeth, K., Sven, F., Optimized conditions for MDCK permeability and turbidimetric solubility studies using compounds representative of BCS classes I-IV, Pharm. Sci., 2002, 15: 331-340.
21. Irvine, J. D., Takahashi, L., Lockhard, K. et al., MDCK (Madin-Darby canine kidney) cells: a tool for membrane permeability screening, J. Pharm. Sci., 1999, 88: 28-33.
22. Mohanmmed, E., Abdel, H., Comparative LC-MS and HPLC analyses of selected antiepileptics and beta-blocking drugs, IL Farmaco, 2000, 55: 136-145.
23. Meunier, V., Bourrie, M., Berger, Y. et al., The human intestinal epithelial cell line Caco-2: Pharmacological and pharmacokinetic application, Cell Biol. Toxicol., 1995, 11: 187-194.